Timothy Coughlin, Director at aTYR PHARMA INC (LIFE), bought 50,000 shares at $1.75 ($88K) on 2024-05-30, disclosed to the SEC on 2024-06-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TVTX | SELL | 2025-11-04 | $631K | — | Filing → |
| FATE | SELL | 2022-06-06 | $33K | — | Filing → |